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Abstract
Background: Avian influenza viruses (AIVs) are endemic in wild birds and their introduction and conversion to
highly pathogenic avian influenza virus in domestic poultry is a cause of serious economic losses as well as a risk
for potential transmission to humans. The ability to rapidly recognise AIVs in biological specimens is critical for
limiting further spread of the disease in poultry. The advent of molecular methods such as real time polymerase
chain reaction has allowed improvement of detection methods currently used in laboratories, although not all of
these methods include an Internal Positive Control (IPC) to monitor for false negative results.
Therefore we developed a one-step reverse transcription real time PCR (RRT-PCR) with a Minor Groove Binder
(MGB) probe for the detection of different subtypes of AIVs. This technique also includes an IPC.
Methods: RRT-PCR was developed using an improved TaqMan technology with a MGB probe to detect AI from
reference viruses. Primers and probe were designed based on the matrix gene sequences from most animal and
human A influenza virus subtypes. The specificity of RRT-PCR was assessed by detecting influenza A virus isolates
belonging to subtypes from H1–H13 isolated in avian, human, swine and equine hosts. The analytical sensitivity of
the RRT-PCR assay was determined using serial dilutions of in vitro transcribed matrix gene RNA. The use of a
rodent RNA as an IPC in order not to reduce the efficiency of the assay was adopted.
Results: The RRT-PCR assay is capable to detect all tested influenza A viruses. The detection limit of the assay
was shown to be between 5 and 50 RNA copies per reaction and the standard curve demonstrated a linear range
from 5 to 5 × 108 copies as well as excellent reproducibility. The analytical sensitivity of the assay is 10–100 times
higher than conventional RT-PCR.
Conclusion: The high sensitivity, rapidity, reproducibility and specificity of the AIV RRT-PCR with the use of IPC
to monitor for false negative results can make this method suitable for diagnosis and for the evaluation of viral
load in field specimens.
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Background
Influenza A viruses belong to Orthomyxoviridae, a family of
enveloped negative-sense, segmented single stranded
RNA viruses. Based on major differences within the
hemagglutinin (HA) and neuraminidase (NA) proteins,
16 HA and 9 NA subtypes have been recognized, all of
which have been isolated from avian species [1-3]. Only
the H1, H2, and H3 subtypes have established stable
humans lineages, whereas H5, H7 and H9 subtypes have
been detected sporadically in humans. Among avian spe-
cies, wild aquatic birds represent the natural reservoir of
all influenza A subtypes from which influenza viruses are
introduced in to all other species affected in nature,
including domestic poultry. Infections of domestic avian
species with low pathogenic avian influenza (LPAI)
viruses can be asymptomatic or cause a wide range of clin-
ical signs varying from mild respiratory disease to more
severe diseases affecting the respiratory and enteric sys-
tems. Highly pathogenic avian influenza viruses (HPAI)
cause rapid mortality in poultry, which often approaches
100% of incidence [4]. There is evidence that LPAI viruses
carried by wild birds can acquire high virulence after
direct transmission to and replication in domestic species.
Genetic reassortment of avian, swine and human influ-
enza viruses was considered, until the 1990s, to be the
main mechanism whereby novel viruses containing ani-
mal virus genes could transmit to humans. However, the
zoonotic events in Asia and in Europe caused by H5N1,
H9N2 and H7N7 subtypes respectively indicate that AIVs
are capable of infecting humans directly [5]. The link
between human and avian influenza has raised concern
among public health authorities and the scientific com-
munity about the prevalence and pandemic potential of
AIVs.
Prompt identification of AIVs circulating in the field can
help control viral spread in poultry, thereby reducing the
potentially serious economic damage as well as the expo-
sure of humans to AIVs. Therefore rapid, highly specific
and sensitive assays are required in avian influenza virus
diagnosis.
Methods in routine use for avian influenza virus detection
and characterization include virus isolation in embryo-
nated eggs followed by identification by haemagglutina-
tion-inhibition (HI) or ELISA tests. Viral culture assay is
quite sensitive, but time consuming and technically
demanding, and requires the presence of infectious viral
particles; instead, ELISA for antibodies or antigen is a test
of limited specificity [6]. An approach for the rapid iden-
tification and detection of AIVs is the application of
reverse transcription-PCR (RT-PCR) [7]. Although PCR is
one of the most sensitive and specific techniques and the
presence of infectious virus is not necessary, the assay
requires multiple manipulations of the samples after the
amplification step, thus increasing the risk of carryover
contamination, and usually does not include an Internal
Positive Control (IPC).
Recently, quantitative, fluorescence-based real-time PCR
assays have been developed in different formats [8-10].
These methods exhibit good sensitivity, broad dynamic
range and are capable of detecting all AIVs subtypes. How-
ever, most of these assays detect influenza virus RNA in
the absence of an internal control; the inclusion of an
amplification control is particularly useful to monitor for
false negative results due to RNA degradation or to inhib-
itory factors, potentially present in clinical samples [11].
This feature can be of critical importance in avian influ-
enza diagnosis: failure to identify a positive AI outbreak in
a poultry farm, particularly in the case of highly patho-
genic viruses, would not allow to adopt promptly the nec-
essary actions for eradication purpose, thus favouring the
undetected spread of the virus to other flocks. This failure
could have even more serious consequences in the case of
domestic ducks, since in these birds infections with highly
pathogenic viruses, such as the H5N1 strains from South
East Asia, are often asymptomatic [4].
RRT-PCR assays with new Minor Groove Binder (MGB)
probes offer several advantages over existing probes [12].
In fact, a DNA probe with conjugated MGB groups forms
a stable duplex with a single-stranded DNA target; there-
fore it can be shorter than those without MGB groups. In
addition the presence of a 3' dark quencher reduces the
background fluorescence. Both this features have been
shown to improve the specificity and sensitivity of MGB
RRT-PCR assay in comparison to RRT-PCR tests using
unmodified DNA probes [12].
In this paper, a sensitive MGB RRT-PCR was developed for
detection of AIVs with the inclusion of an IPC in order to
monitor for possible failures in the diagnostic evaluation
of field samples.
Methods
Viruses
Human influenza type A and type B viruses and a number
of avian viral pathogens used to test the specificity of
influenza A matrix and IPC assays are listed in Table 1 and
were selected from the repository of Istituto Superiore
Sanità laboratories.
A/Turkey/Italy/214845/02 (Ty/214845) H7N3 virus [13]
was propagated in the allantoic cavities of 11-day-old
embryonated chicken eggs to produce working stocks of
the virus for use as reference virus strain for assay stand-
ardization. Virus stocks of Ty/214845 were titrated by end
point dilution in Madin Darby canine kidney (MDCK)
cells, and the 50% tissue culture infectious doses (TCID50)BMC Infectious Diseases 2006, 6:87 http://www.biomedcentral.com/1471-2334/6/87
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were calculated as previously described [14] in a modified
ELISA test that identifies the expression of influenza A
virus nucleoprotein in infected cells. Moreover to deter-
mine the virus titer in 50% egg infectious dose (EID50),
10-day old fertile hen eggs were inoculated with Ty/
214845 and the allantoic fluid was collected and tested
for hemagglutination. The virus titer was determined
using the Reed and Muench method [15]. The Ty/214845
virus, with a TCID50 of 107.34/ml and a EID50 of 108.25/ml,
was used as the stock virus in the assay. A series of 10-fold
dilutions of the stock virus sample in transport medium
were prepared and stored at -80°C until use for RNA
extraction. Transport medium consisted of PBS/Glycerol
(1:1) supplemented with potassium penicillin (1,000 U/
ml), streptomycin sulfate (200 μg/ml), gentamicin sulfate
(240 μg/ml), polymyxin B (100 Unit/ml) and mycostatin
(50 Unit/ml). These antibiotics were from Sigma-Aldrich
Co. (St Louis, MI).
Field specimens
To evaluate the applicability of the test as a diagnostic
method in the screening of field specimens, we analysed
retrospectively one hundred samples collected during sur-
veillance studies in wild waterfowl [16]. Cloacal swabs
were collected from ducks using sterile cotton swabs and
resuspended in the transport medium described above.
Ten of these samples had been shown to be positive for
influenza type A by standard virus isolation procedures.
Twenty pools of five cloacal swabs each were prepared
before viral RNA extraction. Ten of the pools were
obtained mixing one positive with four negative AI sam-
ples, while each of the remaining pools contained five
negative AI cloacal swabs only. All twenty pools were
spiked with IPC RNA before the extraction step (see sec-
tion Internal Positive Control).
Table 1: List of influenza A viruses isolates and other pathogens tested for RRT-PCR specificity assay.
ISOLATE HA SUBTYPE RESULT
A/Mallard/Italy/70/96 H1N1 positive
A/Mallard/Italy/35/99 H2N3 positive
A/Duck/Ukraine/63 H3N8 positive
A/Mallard/Italy/616/01 H4N6 positive
A/Chicken/Italy/312/97 H5N2 positive
A/Mallard/Italy/80/93 H5N2 positive
A/Chicken/Italy/9097/97 H5N9 positive
A/Mallard/Italy/41/00 H6N8 positive
A/Turkey/Italy/214845/02 H7N3 positive
A/Turkey/Ontario/618/68 H8N4 positive
A/Turkey/Wiss/66 H9N2 positive
A/Coot/Italy/125/94 H10N8 positive
A/Mallard/Italy/243/00 H11N6 positive
A/Duck/Alberta/60/76 H12N5 positive
A/Gull/Maryland/704/77 H13N6 positive
A/Equine/New Market/2/93 H3N8 positive
A/Equine/Roma/1/91 H3N8 positive
A/Swine/Italy/1421/95 H1N1 positive
A/Swine/1184/92 H3N2 positive
A/New Caledonia/20/99 H1N1 positive
A/Roma/3/03 H3N2 positive
B/Guandong/120/00 NA negative
B/Yamagata/16/88 NA negative
PMV 2 (Ck/Ca/Yucaipa/56) NA negative
PMV 3 (Tk/1087/82) NA negative
PMV4 (Dk/HK/D3/75) NA negative
TRTV (But 1FF 8544) NA negative
IBDV (D-78) NA negative
IBV (M41) NA negative
NA: not applicable
PMV: paramixovirus
TRTV:turkey rhinotracheitis virus
IBDV:infectious bursal disease virus
IBV:avian infection bronchitis virusBMC Infectious Diseases 2006, 6:87 http://www.biomedcentral.com/1471-2334/6/87
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Primer and probe design
The primers and probe were designed based on the
sequence homology of the matrix gene (segment 7)
among different subtypes of influenza A strains of avian,
human, swine and equine origin. A 147 bp region located
at the 5'end of the matrix gene (nucleotides 32–179),
which represents one of the highly conserved regions of
the virus gene, was chosen as the target region for primer
amplification. The fluorogenic MGB probe, labelled at 5'
with FAM and at 3' with a dark quencher dye, was
designed to anneal to an internal sequence of the ampli-
fied region. The sense and antisense primers and MGB
probe were designated M-Flu1, M-Flu2, and M-Fluprob
(Table 2), respectively, and were designed using the
Primer Express v. 1.5 software (Applied Biosystems, Foster
City, CA).
Standard RNA synthesis
In vitro transcribed matrix gene RNA of Ty/214845 was
used to determine the detection limit of the assay as a pos-
itive control. The entire 1027 bp long matrix gene was
amplified with a specific set of primers (sequences are
available upon request) and the product was purified
using the QIAquick gel extraction kit (Qiagen) and ligated
to the PCR2.1 vector using the TOPO™ TA cloning kit
(Invitrogen Corp, Carlsbad, CA). To verify that the con-
struct obtained (pFluA) had no mutations in the
sequences corresponding to the primers and probe posi-
tions and to determine the sequence and orientation of
the insert, nucleotide sequencing was performed using
ABI BigDye Terminator v. 1.1 sequencing kit and the ABI-
Prism 310 sequencer (Applied Biosystems). The plasmid
pFluA, which possesses a T7 promoter, was linearised at
the end of the matrix protein gene and then purified using
the Wizard DNA Clean-up kit (Promega, Madison, WI).
DNA concentration at two dilutions (1:100 and 1:1000 in
TE buffer, pH 8) was measured as OD units at 260 nm and
the number of plasmid copies in the extract was calculated
from the molecular weight of the plasmid and the insert.
Ten  μg of linearized plasmid was transcribed using
RiboMax kit from the T7 promoter according to the man-
ufacturer's instructions and quantified by spectrophotom-
eter analysis RNA copy number was then determined
following the method of Fronhoffs [17].
Ten-fold dilutions of the RNA transcript, ranging from 1
to 108 copies/μl, were prepared in sterile water and used to
determine the analytical sensitivity of the RRT-PCR assay.
Internal positive control
The rodent glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) RNA was chosen as an IPC. The commercial kit
(supplied by Applied Biosystems) contained GAPDH rea-
gents designed to detect rat, mouse and chinese hamster
GAPDH genes by means of gene specific primers and
probe.
For evaluation of inhibition effects, 25, 2.5, 0.25, 0.025,
0.0025 0.00025 ng of the IPC RNA were added to the RRT-
PCR in addiction to 5 copies of in vitro transcribed matrix
gene RNA. In the evaluation of the extraction phase with
the reference virus, 0.3 ng of RNA IPC were added prior to
this step in order to obtain in the final RRT-PCR a maxi-
mum concentration of 0.025 ng. This was calculated tak-
ing into account that each sample is eluted in 60 μl as
above described and only 5 μl of this mixture is used in
the RRT-PCR.
The GAPDH RNA was detected using forward and reverse
primers and the TaqMan VIC labelled probe, according to
the instructions of the manufacturer, in the multiplexed
RRT-PCR assay described below.
Extraction of viral RNA
Total RNA was extracted from all types of viruses using
QiAmp Viral RNA Mini kit (Qiagen GmbH, Hilden, Ger-
many) according to the manufacturer's instructions.
Briefly, 210 μl of sample containing transport medium
spiked with 6 μl of IPC RNA were mixed with the provided
lysis buffer and left for at least 10 min at room tempera-
ture. After the addition of 560 μl of 97% ethanol, the liq-
uid was repeatedly run in a spin-column more than once
until it was finished. Finally, RNA was eluted in 60 μl of
RNase-free water and, after addition of 20 unit of RNase
inhibitor, was stored at -80°C until use. In the negative
control, sterile water was added instead of the specimen.
Influenza A viruses, listed in Table 1, were also extracted
without IPC RNA, in order to test the rodent primers and
probe specificity.
Table 2: Primers and MGB-probe designed in this work
NAME SEQUENCE (5'-3') LOCATION (nt) SENSE
M-Flu1 CTTCTAACCGAGGTCGAAACGTA 32–54 +
M-Flu2 GGATTGGTCTTGTCTTTAGCCA 158–179 -
M-Fluprob FAM-CTCGGCTTTGAGGGGGCCTGA-MGB 74–94 -BMC Infectious Diseases 2006, 6:87 http://www.biomedcentral.com/1471-2334/6/87
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One-Step Real-Time RT-PCR
RNA from all samples, were amplified by RRT-PCR assay,
run in an ABI Prism 7000 SDS Real-Time apparatus
(Applied Biosystems) using the Superscript III Platinum
One-step qRT-PCR kit (Invitrogen). The 25 μl reaction
volume contained 5 μl of extracted RNA, 1X Superscript
III Platinum One-step qRT-PCR reaction mix, 0.5 μl of
ROX reference dye as a passive reference, 0.2 μM of each
probe and 0.4 μM of each one of the primers for both the
matrix gene and rodent RNA. The following thermal pro-
file was used: a single cycle of reverse transcription for 30
min at 45°C, 2 min at 95°C for reverse transcriptase inac-
tivation and DNA polymerase activation followed by 40
amplification cycles of 15 sec at 95°C and 1 min at 60°C
each (annealing-extension step). Triplicate negative and
positive controls were included in each experiment. Each
fluorescent reporter signal was measured against the inter-
nal reference dye (ROX) signal to normalize for non-PCR-
related fluorescence fluctuations between samples. The
data were collected at the annealing step of each cycle and
the threshold cycle (Ct) for each sample was calculated by
determining the point at which the fluorescence exceeded
the threshold limit.
The standard curve was calculated automatically by plot-
ting the Ct values against each standard of known concen-
tration and by extrapolating the linear regression line of
this curve.
Specificity and analytical sensitivity of RRT-PCR
Primers and probe specificity for type A influenza viruses
and for IPC were assessed by testing amplification of RNA
from influenza virus isolates belonging to the most com-
monly isolated HA subtypes (H1–H13), represented by
either Eurasian or North American lineage avian strains,
human, equine and swine viruses, as well as type B human
influenza viruses and a panel of avian viral pathogens
(Table 1).
To test the analytical sensitivity of the RRT-PCR assay,
RNA extracted from ten-fold diluted samples of Ty/
214845, containing 1 to 0,0001 TCID50 and 80 to 0.008
EID50 of virus were tested. To determine the detection
limit of the assay in terms of matrix gene copies number,
serial dilutions of in vitro transcribed RNA, ranging from 5
× 108 to 5 copies/reaction were analysed. The detection
limit of the assay was determined as the last dilution at
which all 10 replicates of each dilution gave a positive
result.
Reproducibility of RRT-PCR
To calculate the reproducibility of the test, three different
concentrations of the Ty/214845 virus, corresponding to
100, 1 and 0,01 TCID50 respectively, were submitted to
absolute quantification using the standard curve built
with in vitro transcribed RNA (see Standard RNA synthesis
section). Each dilution was quantified in triplicate. The
Coefficient of Variation (CV) for evaluation of the intra-
assay repeatability was calculated by testing the three dilu-
tions ten times in the same experiment. To estimate the
inter-assay reproducibility, the three dilutions of Ty/
214845 virus were analyzed in tests independently run in
different days.
Conventional RT-PCR for detection of avian influenza 
viruses
Conventional RT-PCR for influenza A virus, which ampli-
fies a 244 bp fragment of the matrix gene coding
sequence, was also performed as previously described [7]
on influenza A viruses (Table 1) and clinical specimens.
Results
Specificity
The primer and probe set was capable of detecting all type
A influenza viruses, whereas no signal amplification was
observed with influenza B viruses and other avian patho-
gens. Moreover all samples, including the negative control
for the amplification of the matrix gene, gave a positive
result in the RRT-PCR assay for IPC specific amplification.
In the IPC specificity assay no signal of fluorescence was
obtained using primers and probe specific for rodent RNA
amplification.
Analytical sensitivity
The analytical sensitivity of the influenza A RRT-PCR assay
was determined by amplification of both RNA extracted
from dilutions of a TCID50 and EID50 titrated stock of ref-
erence virus and of in vitro transcribed matrix RNA. The
RRT-PCR assay could detect up to 0.001 TCID50 of the Ty/
214845 reference virus (equivalent to 0.08 EID50) as few
as 5 to 50 RNA matrix gene copies per reaction. Evaluation
of the assay analytical sensitivity was performed in three
different runs. Figure 1 presents one of the experiments
that indicates a linear correlation between the Log of the
matrix gene copy number and the Ct, with a regression
line showing a slope of 3.43 (R2 = 0.998). To compare the
analytical sensitivity of RRT-PCR and RT-PCR, serial dilu-
tions of known amounts of in vitro transcribed RNA were
also tested by conventional RT-PCR. The results demon-
strated that the RT-PCR could detect up to 5 × 102 copies
of RNA/reaction, which represents a 10-100-fold higher
detection limit than that observed with RRT-PCR.
Reproducibility
The intra and inter-assay Coefficients of Variation were
calculated using three dilutions of the Ty/214845 virus,
corresponding to 100, 1 and 0,01 TCID50, in order to sim-
ulate positive samples with a wide range of concentra-
tions. The CV intra-assay for each dilution was 25, 27 andBMC Infectious Diseases 2006, 6:87 http://www.biomedcentral.com/1471-2334/6/87
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30% respectively, whereas the CV inter-assay was 27, 30,
and 41% respectively.
Internal Positive Control and interpretation of results
The decision to include an IPC in the final assay, added to
the matrix gene assay, prompted us to consider the influ-
ence of such additional amplification on the detection
limit for the influenza virus target and the specificity of
the assay to detect the IPC. The highest amount of IPC
RNA, which did not influence the Ct for matrix gene RNA
amplification, was equal to 0.025 ng/reaction. This
amount was then added to the sample containing the low-
est amplified quantity of reference virus, corresponding to
0.001 TCID50 prior to the extraction step. The amplifica-
tion of matrix gene RNA confirmed that the detection
limit of the reference virus was not influenced by the pre-
viously established amount of IPC.
Detection of viral RNA in field samples
To assess whether the RRT-PCR assay allows the detection
of viral RNA in biological samples collected in the field,
twenty pools of cloacal swabs, obtained from one hun-
dred faecal samples collected from wild birds, were tested
by RRT-PCR. The assay detected the presence of influenza
A virus RNA in ten pools, previously found to be positive
by both virus culture and conventional RT-PCR (data not
shown). For the remaining ten pools, a positive signal was
obtained only for rodent RNA, indicating the absence of
false negative results.
Discussion
The epidemics of avian influenza in Asia and, more
recently, in some European regions [18], have caused con-
siderable public concern and raised the need of continued
vigilance for rapid virus detection in poultry. Rapid and
sensitive influenza diagnosis in domestic birds is funda-
mental to allow the implementation of control measures
aimed at containing the outbreaks in poultry, reducing
human exposure. Moreover, early influenza detection is
important for the screening of potential carriers of influ-
enza A such as wild birds, whose role in the H5N1 spread
throughout Asia and most European countries has been
hypothesised [18].
Methods used for influenza A identification in birds
should be specific enough to allow detection of antigeni-
cally and genetically different influenza subtypes. Among
them, the RT-PCR technique is widely used to detect influ-
enza viruses directly in specimens collected from animal
species susceptible to influenza virus infection and from
humans [7].
Recently, new molecular approaches have been described,
involving specific fluorogenic probes that allow the simul-
taneous amplification and visualization of the viral
nucleic acid in real-time. Indeed, RRT-PCR assays improve
the sensitivity and specificity of gene detection, reduce sig-
nificantly hands-on time, and allow quantitation of the
total amount of nucleic acids.
In this study we present data on a highly sensitive assay for
AIV detection by real-time RT-PCR, based on the new
MGB probe technology, which includes the use of an IPC
to monitor for false negative results. Moreover, our assay
could be easily adapted in a quantitative format by using
a previously quantified RNA to create a standard curve to
which results from unknown samples can be compared.
For this purpose, we designed primers and a probe specific
for a region of the matrix gene that is strictly conserved for
most influenza A sequences available. In this way, we
expected to be able to detect influenza A viruses belonging
to all subtypes, and lineages within subtypes. The col-
lected results showed that our RRT-PCR assay is highly
specific for detection of all tested influenza A virus strains.
A novel MGB probe for matrix gene detection was used;
this type of probe has melting temperatures higher than
the common Taq-Man probes, thus allowing the hybridi-
zation to the target sequence and consequently the gener-
ation of fluorescence signals, even also in the presence of
possible mutations within this highly conserved region.
Although single-step RRT-PCR is reported to be less sensi-
tive than a two-step amplification method [19], the use of
a one-step RRT-PCR was performed in this study to pre-
Standard curve of the matrix gene real-time RRT-PCR assay Figure 1
Standard curve of the matrix gene real-time RRT-PCR assay. 
Serial 10-fold dilutions of in vitro transcribed matrix RNA 
standard (from 1 to 10 8 copies/μl) were plotted against the 
threshold cycle. Each plot represents the mean of 10 repli-
cate amplifications of each dilution. The coefficient of deter-
mination (R2) and the equation of the regression curve (y) 
calculated.BMC Infectious Diseases 2006, 6:87 http://www.biomedcentral.com/1471-2334/6/87
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vent the risk of cross contamination and to increase the
speed of the test. Moreover, the proposed RRT-PCR assay
was 10-fold more sensitive compared to the RRT-PCR
already published [9,10] and 10–100 fold more sensitive
than conventional RT-PCR. This is extremely important in
routine diagnostic studies particularly when the amount
of influenza A virus RNA in field specimens is low.
Multiple negative controls as well as positive controls
should be included in diagnostic RRT-PCR in order to
achieve an acceptable level of confidence for the absence
of false-positive and/or false-negative results. However,
since such controls are generally run in separate tubes, no
information about the performance of the extraction and
amplification reaction in the sample-containing tubes is
usually available. In particular, if amplification is partly
inhibited or if there is a partial loss of nucleic acid during
sample processing, the sample Ct of IPC will be higher
than under ideal conditions, and will consequently yield
an artificially low RNA reading on the standard curve [11].
To circumvent this problem, in our system an IPC was
added to each sample before the extraction step; it consists
of a second target sequence, represented by a rodent RNA,
unrelated to the sequence to be detected and available in
a commercial kit. Adding the IPC before influenza RNA
isolation allows monitoring of the whole process from
extraction to RRT-PCR [20,21]. Furthermore, this IPC can
be used in multiplex RRT-PCR for detection of other path-
ogens. Important problems in multiplex RRT-PCR assays
with an IPC are competitive effects and loss of sensitivity
[20,21] that could be avoided by using low concentra-
tions of the IPC. Nevertheless, an inhibition of IPC ampli-
fication could be observed also when very high amounts
of RNA target were present. When this partial or complete
inhibition of IPC detection caused by high amounts of
target RNA occur, it is not significant since IPC is used to
monitor for false negative results in the presence of low
levels of target RNA [20]. The choice of an RNA as internal
positive control was made considering the public availa-
bility of such reagents, and represents a potential possible
first step in the harmonization of the RRT-PCR assay for
influenza diagnostic.
The test described is extremely sensitive, being able to
detect 5 to 50 gene copies/reaction of in vitro transcribed
RNA. The minimum detectable amount of AI reference
virus corresponded to 0.001 TCID50/reaction and 0.08
EID50/reaction respectively.
Detection limits for the influenza A virus matrix gene
assessed in other TaqMan-PCR assays ranged from 0.006
to 0.2 TCID50/ml [22,23,7]. Nevertheless, a comparison
of the sensitivity between the different formats of RRT-
PCR is difficult because of the use of different viral strains,
viral concentration methods and lack of IPC. The availa-
bility of reference material is of paramount importance to
compare the sensitivity of different diagnostic assays par-
ticularly in the light of the current avian influenza H5N1
crisis which would require a global approach in diagnostic
laboratories [24]. Finally, results indicate that our test has
a good reproducibility, as shown by a low CV within and
between performed assay.
The suitability of the RRT-PCR test described in this study
as a diagnostic tool for AIV detection was confirmed by
testing samples taken from naturally infected birds. In
comparison with conventional RT-PCR, the number of
viral genome molecules of standard RNA detected by RRT-
PCR assay was found to be 2 log lower in these specimens.
Conclusion
The MGB assay described here could be used for the detec-
tion of all subtypes of influenza A viruses tested. Quanti-
fication of viral load could be important in the study of
viral replication both in cell culture models and in ani-
mals experimentally infected. This quantification could
provides useful tool to evaluate the efficacy of new vac-
cines and antivirals against AI [25]. This assay, with the
insertion of standard curves or a calibrator sample in each
run could be easily adapted in a quantitative format.
RRT-PCR tests for avian influenza virus detection have
been developed in different formats [26,9,10]. Most of
them recognise highly conserved sequences within type-
specific genes, such as that coding for the matrix gene,
alone or in combination with primers and probe specific
against the H5 and/or H7 hemagglutinin subtypes, those
capable of evolving into a highly pathogenic phenotype.
The inclusion of the IPC in the assay represents an
improvement in the design of a RRT-PCR; IPC is useful to
monitor for false negative results due to PCR failure
caused by expired reagents, poor technique, equipment
failure or presence of enzyme inhibitors in biological
samples. Moreover the possibility of screening a large
number of samples in a rapid, sensitive and reproducible
way could make this assay a possible suitable tool for the
routine diagnostic laboratories possessing a RRT-PCR
equipment. Infact, although the analysis of a small
number of field samples has been reported, this is a first
step in the field validation of our RRT-PCR assay and
more extensive work, involving the application of the
assay on field samples, including also specimens from
poultry, will be necessary in the future.
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